IRD CIK: 1228627

Opus Genetics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.4
FY22:
14.3
FY23:
−1.11
FY24:
−25.6
FY25:
−35.3
Change from FY21 to FY25
millions USD
FY21:
−0.10
FY22:
0
FY23:
0
FY24:
1.21
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
27.6
FY22:
3.79
FY23:
8.98
FY24:
4.19
FY25:
50.0

All amounts in millions USD Data source:SEC EDGAR